Introduction
Periodontal therapy continues to heavily emphasize predictable regeneration of the periodontal attachment apparatus. This attachment apparatus includes the alveolar bone, the periodontal ligament and the cementum, the mineralized outermost layer of the tooth root. This attachment is destroyed as a result of the inflammatory response that occurs with progression of periodontitis. Once the clinical symptoms of inflammation and signs of disease are controlled, the major goal of periodontal therapy is to regenerate these tissues and re-establish their normal relationship. However, surgical repair, not regeneration, is the most common result of traditional periodontal treatments.
Recent research suggests that human recombinant bone morphogenic protein-2 (rhBMP-2) can accelerate the regeneration of not only bone but also the cementum and the insertion of periodontal ligament fibers. 1 But some studies have demonstrated that rhBMP-2 has limited regenerative ability and results in a deranged periodontal relationship, with complications such as ankylosis and root resorption. 2, 3 It has been suggested that the incidence of the ankylosis relationship between the components of the regenerated periodontal apparatus and the extent of root resorption positively correlates with the dose of rhBMP-2. 4 Therapy with rhBMP-2 is limited by protein degradation and inactivation. 5 Slower release of rhBMP-2 and more prolonged exposure can increase cementogenesis and yield a healthier relationship among the related tissues, 6 but the need for a supraphysiological concentration and a related increase in the risk of root resorption are major disadvantages of this approach. 7 Gene transfer offers a means to prolong the delivery of signaling molecules. 8 It has been proposed that a gene transfer approach would yield sustained BMP-2 production and more complete repair of bony lesions. 9 Investigation of the effectiveness of this potential periodontal treatment strategy using ex vivo gene transfer of BMP-7 through syngeneic dermal fibroblasts yielded successful results. 10 Adult bone marrow mesenchymal stem cells (MSCs) can be engineered to express an assortment of factors in vivo; moreover, they have been demonstrated to respond to these factors and differentiate into skeletal specialized cells. 11 This allows them to actively contribute to periodontal tissue regeneration. Relative to the fibroblast approach, more prolonged and efficient delivery of BMP-2 can be accomplished in vivo when using viral vectors to introduce the BMP-2 gene into MSCs. 12, 13 Periodontal regeneration therapy with transplanted MSCs has been shown to increase the regeneration of the cementum, periodontal ligaments and alveolar bone.
14 In a previous study, MSCs were induced into an osteogenic phenotype, such that they were able to repair alveolar bone defects (5-mm high) without investigating the periodontal attachment apparatus. 15 Previously, we reported that replication-defective adenoviral BMP-2 gene transfer to MSCs increased bone formation in critical-sized craniofacial bony defects. [16] [17] [18] By virtue of the autocrine and paracrine effects of genetransferred MSCs, BMP-2 is secreted continuously for several weeks, yielding greater amounts of bone regeneration. Fluorescence in situ hybridization analysis at 2 weeks revealed that implanted male MSCs in female femoral segmental repair not only act as BMP-2 deliverers, but also participated directly in the bone formation process by having differentiated into osteoblasts. 19 Therefore, application of replication-defective adenoviral BMP-2 gene transfer to MSCs in periodontal regenerative therapy might represent a better approach for delivery of BMP-2. In addition, by preventing the unfavorable complications of high-dose rhBMP-2, a more normal regeneration of the periodontal attachment apparatus might be achieved.
This gene therapy approach requires a three-dimensional scaffold to seed cells and support their proliferation during defects. Pluronic F127 (PF127) is a polyethylene and polypropylene oxide copolymer that exists in a liquid state when cold and solidifies into a gel at physiological temperatures (approximately 37 1C). PF127 has been shown to facilitate the early attachment of human gingival fibroblasts and increase their growth rate, 20 and has also proven advantageous in cartilage tissue engineering. 21, 22 The aim of this study was to investigate the regeneration ability of osseous tissue and the periodontal attachment apparatus in surgically created transgingival periodontal defects following implantation of autologous MSCs engineered ex vivo to express the BMP-2 gene and using PF127 as a scaffold.
Results
Directly before implantation, the phenotype of the MSCs in the three experimental groups did not differ; all were CD11 aÀ , CD44 + and CD90.1 + . No adverse reactions or infection occurred during the 6-week healing interval. All surgical implantation defects healed uneventfully and with limited signs of inflammation. Immunoprecipitation and western blot analysis in the advBMP-2 group showed that the adenovirusmediated BMP-2 gene was positively expressed and processed in MSCs, as the molecular weight of secreted BMP-2 indicated a mature status without any prepeptide formation (Figure 1d ). A band with fragment size greater than 33 kDa was noted on the non-reduced (oxidized or active) proteins. The band with fragment size greater than 19 kDa was eminent on the reduced (inactive) proteins. The BMP-2 concentrations, right before implantation, were 12.20 ± 0.60 and 0.06 ± 008 ng ml À1 in the advBMP-2 group and the MSC group, respectively (Po0.001). The in vivo local concentration of BMP-2 was as follows: first week, 2447.92±195. 22 . Six weeks after surgery, group differences in the regeneration of the periodontal apparatus were apparent ( Figure 2 ). There was no evidence of residual PF127, and all specimens were free from ankylosis. The advBMP-2 group exhibited considerably greater amounts of new bone formation, extending from the apical aspect of the defect through the coronal extension (Figures 2a, e, i and m). Connective attachments were observed (Figure 2a) . Moreover, root surfaces were covered with continuous layers of cementum ( Figure  2e ). Typically, new cementum with Sharpey's fibers was observed on the instrumented root surface. Meanwhile, newly formed periodontal ligament fibers were functionally orientated and new connective tissue fibers were inserted into both the new cementum and the new bone (Figures 3a and b) . The sparse stroma and fibrovascular space were densely populated with cells and comprised scattered fine bundles of collagen fibrils (Figure 3c ). The newly regenerated trabecular bone was covered by a thick layer of osteoid and osteoblasts with continual bone-forming activity (Figure 3e) . A narrow marrow space was evenly dispersed among the bone trabeculae (Figure 2i ). The mature lamellar bone was formed (Figure 2i ). The blend of woven and lamellar bone, in the central part of the new bone, displayed a mature physiological form (Figure 3d ). The presence of a reversing line and osteoclasts with resorption pits suggested simultaneous occurrence of a slow remodeling process ( Figure 3d ). Von Kossa silver staining demonstrated strong mineralization of the newly regenerated bone (Figure 3f ).
The advbgal group exhibited woven bone formation, extending from the apical aspect of the defect to the middle of the root (Figures 2b, f, j and n). Covering of small root resorption area with regenerated cementum and fiber insertion was noted (Figure 2f ). Some cementodentinal junctions had a scallop-shaped appearance, indicating that there had been surface resorption of the root dentin before the new cementum was formed (Figure 2f ). At the junction of the tooth attachment, there was no cementum on the irregularly resorbed root surface; it was replaced with a penetration of unevenly attached epithelium (Figure 2b ). Moderate downgrowth of the junctional epithelium was observed. Furthermore, newly formed bone trabeculae were observed with a wide fatty marrow space, and the lamellar bone was lined with flat osteoblast-like cells (Figure 2j ). We used three-dimensional computer tomography images to examine the total volume of regenerated bone. We examined group differences in regenerated bone volume using analysis of variance with the SNK procedure for post hoc multiple comparisons. The advBMP-2 group had the highest mean regenerated bone volume (Po0.01); there were no significant differences between the other three groups ( Table 1) .
The transduction rate of MSCs is consistent over 80% in our laboratory (Figure 4a ) by staining b-galactosidase from medium after infection in the advbgal group. The in vivo study of gene expression has been evaluated by immunohistochemistry for b-galactosidase in the advbgal group; the 6-week tissue sections revealed negative (Figure 4b ).
Discussion
The goal of a tissue engineering approach to regeneration of the periodontal apparatus is to overcome the limitations of past periodontal therapies and develop more reliable and predictable periodontal regeneration. 23 At present, the most popular but unpredictable clinical application is guided tissue regeneration, using a cell impermeable Gortex membrane, with or without dried Periodontal regeneration by ex vivo gene medicine Y-L Chen et al frozen dematerialized bone allograft or growth factor in collagen. This ex vivo approach of adenovirus-mediated BMP-2 infection of MSCs has already been shown to successfully regenerate bone in various bony defects and using different scaffolds. 17, 18 Regeneration of the periodontal apparatus involves three different tissue types with complex inter-relationships. Our study demonstrates that gene-transferred autologous MSCs may be able to regenerate all the three tissues simultaneously.
To achieve better results with regard to tissue quantity and quality, space provision is an essential factor in the regeneration of alveolar bone and cementum in periodontal defects. 24 The combination of MSCs and thermoreversible PF127 gel can be easily delivered using an 18-gauge needle. 21, 22 It has been suggested that PF127 can enhance early wound healing in third-degree burns; it has also been considered as a carrier for osseous graft materials and growth factors. 25 PF127 facilitated the spread, attachment and growth of human gingival fibroblasts. 20 PF127 increased transgene expression and is a suitable carrier for regional gene therapy. 26 Our study supports the suitability of PF127 in this respect by its consistency and tenting effect. In this way, it might apply to a stress or weight-loaded defect and maintain more space for bone and periodontal tissue to regenerate as much of the original morphology as possible.
The primary concerns in periodontal regeneration are osteogenesis and cementogenesis; therefore, the rate of cementogenesis appears to be the most important factor. The success of periodontal regeneration depends on early induction of cementogenesis, with rapid colonization and synthesis of the extracellular matrix by cementoblasts along the root surface, followed by the morphogenesis of Sharpey's fibers inserting into the newly formed cementum on the root surface. 4, 27, 28 The initial resorption of root covered with new cementum indicates an interaction between cells and dental substrate. 29 Cemental protein extracts are key factors and regulators of chemoattraction and cell differentiation and are therefore critical during periodontogenesis. 30 This is consistent with our histological findings, showing some small areas of root resorption covered by new cementum and Sharpey's fiber insertion.
Dental tissue (dentin and cementum) may promote the differentiation of cementoblast precursors within the bone cell population. 31 The similar staining patterns of osteoblasts and cementoblasts in cellular cementum indicate that they are phenotypically similar and may be derived from a common osteoprogenitor cell. [32] [33] [34] Therefore, it has been hypothesized that reparative cementum is derived from osteoblasts. Those osteoblasts and their precursors might be a target of BMP-2. 35 BMP-2 may induce new cementum in addition to de novo bone formation. 32 In a previous study, the early effect of BMP-2 on cell recruitment resulted in a nearly threefold increase in cementogenesis by stimulating earlier cell recruitment. 36 It has been suggested that slower release of BMP-2 and more prolonged exposure could increase cementogenesis. [37] [38] [39] Accordingly, enhanced cementogenesis might be achieved through the slower BMP-2 release accomplished with ex vivo gene transfer.
The process of wound healing in periodontal regenerative therapy has been conceptualized as a race between migrating epithelium and connective tissue, including bone and periodontal ligaments. Many studies have noted that multipotent stem cells originating from the periodontal ligament space can transform into cementoblastic and osteoblastic cells capable of regenerating a new attachment apparatus. 40 Therefore, the main concept behind guided tissue regeneration is to use a Gortex membrane to prevent the rapid downgrowth of epithelium, which forms a long junctional epithelium attachment, and to provide sufficient time for regeneration of the periodontal ligament, cementum and bone, whose regenerative rates are slower. Connective tissue formation during the early stage of periodontal regeneration plays a significant role in establishing the final relationship between the elements of the periodontal attachment apparatus. It has been proposed that connective tissue formation processes are the primary mechanisms for inhibition of epithelial downgrowth. 37 Despite the notable induction of mesenchymal cell differentiation by BMP-2, it has also been suggested that the transforming growth factor-b superfamily, of which BMP-2 is a member, can inhibit epithelial downgrowth. 39 Our histological assessment of the advBMP-2 group supports the idea that BMP-2 inhibits epithelial down- growth. This group exhibited better regeneration of the periodontal attachment apparatus than did the other groups.
The advbgal and MSC groups exhibited greater bone regeneration than did the PF127 group. MSCs may have been the primary contributing factor as they offered a source of cells that were ready to regenerate. 14, 41, 42 There is dynamic secretion of transduced BMP-2 protein in vivo and the concentration of local BMP-2 may be affected by the niche. The ex vivo culture may be controlled by the total fluid amount, CO 2 and O 2 conditions without any other protein interference. Therefore, the concentration of BMP-2 in vivo is unable to be accurately estimated. The correlation of local BMP-2 concentration with local osteogenic change is unable to be established. In addition to targeting an osteoinductive gene to a desired site, the ex vivo approach has the additional advantage of supplying MSCs that are capable of participating in osteoinduction. MSCs have inherent osteogenic capacity and can respond to BMP that they have been engineered to secrete. 43, 44 This enables them to actively contribute to periodontal tissue regeneration. The approach used here for the advBMP-2 group provided a larger quantity of osteoprogenitor cells into which MSCs can differentiate, to support osteogenesis and cementogenesis within the connective tissue between bone and tooth. Recently, stem cells from dental pulp 45 and exfoliated deciduous teeth 46 were successfully isolated and may offer another resource for stem cell therapy, but there is limited supply as difficult to access. Our results show that the proposed approach yields better regeneration of bone and cement and overall more predictable and satisfactory regeneration of the periodontal attachment apparatus.
The release of BMP-2 protein can stimulate transgingival regeneration in areas of periodontal defects, including regeneration of bone, the periodontal ligament and cementum. In the advBMP-2 group, there was a greater regenerated, well-mineralized bone volume, without root ankylosis and resorption. New cementum was also inserted with functional orientated periodontal Sharpey's fibers. Ex vivo gene transfer using stem cells as vectors might provide the benefit of slower BMP-2 release, enhancing cementogenesis. This supports the regeneration of the periodontal attachment apparatus and a healthier relationship between the components of the periodontal attachment-in contrast to the unhinged periodontal relationship established following direct treatment with the protein (rhBMP-2). Thus, this approach may be an alternative for periodontal alveolar bone graft in clinical settings.
For the duration of gene expression by the immunohistochemistry of b-galactosidase, the 6-week tissue sections revealed negative. No evidence remained for continuing expression of BMP-2 protein in the implanted site after 3 months. 18 As the active life span for human osteoblast is believed to range from 1 to 10 weeks, at which time these cells may disappear (that is, through apoptotic mechanism). Therefore, the length of gene expression may be long enough for regeneration.
Further study is needed to improve the properties of the three-dimensional scaffold and determine the feasibility of applying BMP-2 gene-engineered autologous MSCs to a larger animal model to cure pathologically exposed periodontal defects.
Materials and methods
All animal procedures were conducted in accordance with the guidelines of the Animal Care and Use Committee of Chang Gung Memorial Hospital.
Aspirates from the iliac crests of New Zealand white rabbits were prepared and processed (Figure 1a) . 47 MSCs were isolated and passaged to a cell density of 50 Â 10 6 cells per ml. The E1-deleted adenovirus BMP-2 (advBMP-2) was a replication-defective vector. 13 The adenovirus b-galactosidase (advbgal) containing the lac z gene was constructed in the same manner as the control vector. 12 PF127 (BASF, Mt Olive, NJ, USA) powder was mixed with Dulbecco's modified Eagle's medium and 10% fetal bovine serum (complete medium) to yield a 25% (w/v) solution of copolymers and filtered at 4 1C. MSCs were mixed with PF127 at a concentration of 50 Â 10 6 per ml, and the construct was solidified into gel form over 10 min in an incubator.
Flow cytometry
Aliquots (1 Â 10 6 cells) of MSCs were prepared directly before surgical implantation. The MSCs were stained with a fluorescein isothiocyanate-conjugated anti-rabbit CD44 antibody (Chemicon, Temecula, CA, USA), fluorescein isothiocyanate-conjugated anti-rabbit CD11a antibody (BioLegend, San Diego, CA, USA) and fluorescein isothiocyanate-conjugated anti-rabbit CD 90.1 antibody (BioLegend). Flow cytometric analysis of cell-surface CD44 was performed using a FACSCanto analyzer (BD Biosciences, San Jose, CA, USA). The cells were washed with 2 ml phosphate-buffered saline (PBS)/bovine serum albumin, resuspended in 0.2 ml FACS buffer and analyzed for the expression of the aforementioned antigens using ACSDiVa software for data collection and analysis (BD biosciences, Franklin Lakes, NJ, USA).
Western blot detection of adenovirus BMP-2 expression in MSCs
Mesenchymal stem cells were grown in complete medium to 90 percent confluence in a roller bottle. The cells were infected with 20 ml of virus working stock of adenovirus b-Gal or adenovirus BMP-2 (10 7 plaqueforming units per ml) at a multiplicity of infection of 50. The infected cells were maintained in complete medium. The medium was collected 7 days later.
Ten microliters of mouse monoclonal antibody (antihuman BMP-2 antibody; R&D Systems Inc., Minneapolis, MN, USA) was added to the 25 ml of medium and incubated for 2-3 h at 4 1C. Fifty microliters of protein A Sepharose (Amersham Pharmacia Biotech, Piscataway, NJ, USA) was added at 4 1C and incubated overnight. The medium was centrifuged at 1500 r.p.m. for 5 min and the pellet (precipitated immune complexes) was collected.
Collected culture medium was mixed with SDS loading buffer w/o NuPAGE reducing agent (Invitrogen, Carlsbad, CA, USA) and heated at 95 1C for 5 min. Samples were separated by reduced SDS-polyacrylamide gel electrophoresis and electrotransferred to a nitrocellulose membrane (Millipore, Bedford, MA, USA). The membrane was blocked with 5% non-fat milk in PBST buffer (PBS containing 0.05% Tween 20) for 1 h at room temperature and then incubated with mouse anti-human monoclonal antibody (Abcam, Cambridge, UK) at 1:500
Periodontal regeneration by ex vivo gene medicine Y-L Chen et al dilution in PBST buffer for 1 h at room temperature. The membrane was washed three times with PBST buffer, followed by incubating in sheep anti-mouse horseradish peroxidase-conjugated secondary antibody (Abcam) at 1:10 000 dilution in PBST buffer for 1 h at room temperature. The membrane was washed three times with PBST buffer and the expressed proteins were visualized using DAB-PLUS kit (Zymed, Carlsbad, CA, USA).
48,49

BMP-2 immunoassay
Right before implantation and each week after implantation, the media were collected from cultured transduced and non-transduced MSCs to allow BMP-2 expression, which was confirmed using an enzyme-linked immunosorbent assay kit (Quantikine BMP-2 Immunoassay).
Animal model
Gene-transferred MSCs were implanted into newly created 15 Â 7 Â 5 mm 3 alveolar bony defects ( Figure  1a ). Bilateral transgingival periodontal defects were surgically created over the palate in 12 adult male New Zealand white rabbits (weight 3 kg). The root surfaces of the maxillary main incisors were denuded and curetted to remove residual periodontal tissue and cementum (Figures 1b and c) . Twenty-four defects were created. After creating the bony defects, 2 ml constructs were implanted in each defect. All rabbits were intubated and anesthetized, and the wounds were closed in a water-tight manner. Parental antibiotic injections were performed for 3 days.
The defects were randomly assigned to four treatment groups. The three experimental groups were implanted with MSCs: the advBMP-2 group was implanted with adenovirus-mediated BMP-2 gene-infected MSCs and PF127; the advbgal group was implanted with adenovirus-mediated bgal gene-infected MSCs and PF127; and the MSC group was implanted with MSCs and PF127. The fourth group was a control wherein only the PF127 polymer was implanted. The rabbits were killed 6 weeks after surgical implantation, the duration of normal initial healing of the periodontal attachment apparatus.
Histological examination
Harvested samples were fixed in buffered 10% formalin for 72 h and sawed into two halves. The decalcified half was stained with hematoxylin and eosin and Masson trichrome blue. The non-decalcified half was stained with Von Kossa's silver nitrate.
In vivo gene expression b-galactosidase activity was determined in the advbgal group by enzyme histochemistry using X-gal (5-bromo-4-chloro-3-indolyl-b-D-galactopyranosine) as substrate (b-galactosidase Reporter Gene Staining Kit; Sigma Co., St Louis, MO, USA). For immunohistochemistry, tissue sections were deparaffinized, rehydrated and digested for 1 h at 37 1C with chondroitinase ABC (0.5 U ml À1 ) in 50 mmol l À1 Tris-HCl (pH 7.3). Thereafter, the sections were washed and incubated for 10 min in serumblocking solution. The distribution of b-galactosidase was studied. Next, the sections were incubated for 30 min in color reaction solution containing 0.2 mg ml . Finally, the sections were counterstained with hematoxylin. 50 Three-dimensional computed tomography model Three-dimensional computer tomography images were acquired immediately following surgery and after being killed. The three-dimensional computer tomography data were reformed, and the size of the voxel unit was set to 0.27 mm 3 . 51 Data reformation, image display and measurement of regenerated bone volume were carried out using Analyze 5.0 (Biomedical Imaging Resource, Mayo Foundation, Rochester, MN, USA).
